132451-33-3

Upstream product

• 106-53-6 para-bromobenzenethiol 
• 132451-32-2 2-(5-Methyl-2-phenyl-4-oxazolyl)ethyl Bromide 
• 103788-64-3 methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetate 
• 103788-65-4 (5-methyl-2-phenyloxazol-4-yl)ethanol 
• 98-88-4 benzoyl chloride 
• 39741-26-9 N-benzoyl-L-aspartic acid β-methyl ester 
• 100373-13-5 methyl 3-benzamido-4-oxovalerate 

Downstream Products

• 132451-34-4 4-[2-(5-methyl-2-phenyl-4-oxazolyl)-ethylthio]benzaldehyde 
• 141200-66-0 5-<4-<<2-(5-methyl-2-phenyl-4-oxazolyl)ethyl>sulfonyl>benzyl>thiazolidine-2,4-dione 
• 132451-22-0 5-[4-[2-(5-Methyl-2-phenyl-4-oxazolyl)-ethylthio]benzyl]thiazolidine-2,4-dione 
• 132451-21-9 5-<<4-<<2-(5-methyl-2-phenyl-4-oxazolyl)ethyl>thio>phenyl>methylene>thiazolidine-2,4-dione 

Relevant academic research and scientific papers

Thiazolidinedione derivatives as hypoglycemic agents

Hypoglycemic thiazolidine-2,4-dione derivatives of the formula STR1 wherein the dotted line represents a bond or no bond; V is --CH=CH--, --N=CH--, --CH=N--, S, O or NR; W is S, SO, SO2, SO2 NR1, NR1 SO2/s

Novel Thiazolidine-2,4-diones as Potent Euglycemic Agents

A new series of thiazolidine-2,4-diones was obtained by replacing the ether function of englitazone with various functional groups, i.e., a ketone, alcohol, or olefin moiety.These compounds lower blood glucose levels in the genetically obese and insulin-r

Thiazolidinedione derivatives as hypoglycemic agents

Hypoglycemic thiazolidine-2,4-dione derivatives of the formula wherein the dotted line represents a bond or no bond;, V is -CH=CH-, -N=CH-, -CH=N-, S, O or NR;, W is S, SO, SO2, SO2NR1, NR1SO2, CONR1 or NR1CO;, X is S, O,